“They're kind of like a hidden superhero in your body and we just didn't know they existed. Muse cells eat the damaged cells, and they can actually turn into new cells using the cellular machinery.”

Dr. Adeel Khan is a global thought leader in regenerative medicine. He is the CEO and Founder of and founder of Eterna Health, whose work with MUSE cell therapy—developed in collaboration with its discoverer, Professor Mari Dezawa—has made him the go-to expert for world leaders, athletes, and celebrities Chris Hemsworth, Kim Kardashian, and Tony Robbins. In this episode, we move beyond the hype of "anti-aging" to explore the hard science of Muse cells (Multilineage-differentiating Stress-Enduring cells). Dr. Khan breaks down how these unique cells differ from the "medicinal signaling cells" (MSCs) found in most clinics and how they act as a bridge to a future where tissue regeneration is standard care.

(0:00) The "Repair Guys" & The Muse Difference Dr. Khan explains why traditional stem cells (MSCs) often disappoint and how Muse cells offer the "best of both worlds": safety and pluripotency.

(2:19) Smart Cells: How They Find the Damage Understanding the "homing mechanism" that allows Muse cells to sense inflammation and instinctively travel to injured areas like the brain or heart.

(3:11) Curing the Incurable: Diabetes & Alzheimer's The potential of the "cure triad"—stem cells, gene therapy, and FMT—to treat complex autoimmune diseases within the next decade.

(4:40) Biological Noise & The Symphony of Health How "static" in our gene expression indicates aging, and how cellular therapy can reduce this noise to restore the body's harmony.

(6:40) The Viral Monkey Study Dr. Khan discusses a recent study showing significant de-aging in monkeys through high-frequency cell dosing.

(7:32) Unshakeable Foundations: Lifestyle as Medicine
Why advanced therapies must be paired with purpose, community, and mindfulness to create a "bulletproof" body.

(8:44) From Sketchy to Standardized
Navigating the regulatory landscape: why Muse cells are being classified as a drug in regions like the UAE and the path toward FDA approval.

(12:24) A Personal Mission
Dr. Khan shares the origin of his journey: trying to find solutions for his mother's chronic illness when traditional medicine failed.

(14:16) The Cancer Hunter
Unlike other pluripotent cells that risk tumor growth, Muse cells have a unique mechanism that can detect cancer cells and trigger their death.

(18:30)Future Outlook: AI, Nature & Blue Zones Reflections on the risks of AI, the importance of "Blue Zone" city design, and reconnecting with nature in a post-human world.

Episode Website

www.creativeprocess.info/pod

Instagram:@creativeprocesspodcast

"The repair mechanisms don't work as well as you get older... The whole idea was: if we can give you more of the 'repair guys,' maybe we can reverse disease."

Dr. Adeel Khan is a global thought leader in regenerative medicine. He is the CEO and Founder of and founder of Eterna Health, whose work with MUSE cell therapy—developed in collaboration with its discoverer, Professor Mari Dezawa—has made him the go-to expert for world leaders, athletes, and celebrities Chris Hemsworth, Kim Kardashian, and Tony Robbins. In this episode, we move beyond the hype of "anti-aging" to explore the hard science of Muse cells (Multilineage-differentiating Stress-Enduring cells). Dr. Khan breaks down how these unique cells differ from the "medicinal signaling cells" (MSCs) found in most clinics and how they act as a bridge to a future where tissue regeneration is standard care.

(0:00) The Future of Regenerative Medicine

(6:13) The Muse Difference: Why these cells are "pluripotent" (able to become any tissue) without the cancer risks of Yamanaka factors.

(10:29) Curing the Incurable: Diabetes & Alzheimer's

(11:27) The Cure Triad: How combining stem cells, gene therapy, and Fecal Microbial Transplants (FMT) could cure complex autoimmune diseases within a decade.

(12:56) Biological Noise: Measuring the "mistakes" in our gene expression to quantify aging.

(16:42) Lifestyle as Medicine: Why Dr. Khan prescribes community, mindfulness, and nature immersion alongside advanced therapies.

(18:13) From Sketchy to Standardized: The Regulatory Landscape

(23:25) A Personal Mission: Trying to Save Mom

(25:38) The Cancer Hunter: How Muse cells naturally detect and trigger cell death in tumors.

(29:02) Quantum Biology & Healing Frequencies
(41:13) The AI Pessimist: Planning for a Post-Human World

(44:03) Reconnecting with Nature

Episode Website

www.creativeprocess.info/pod

Instagram:@creativeprocesspodcast

“ I think we're betting on AI as something that can help to solve a lot of problems for us. It's the future, we think, whether it's producing text or art, or doing medical research or planning our lives for us, etc., the bet is that AI is going to be great, that it's going to get us everything we want and make everything better. But at the same time, we're gambling, at the extreme end, with the future of humanity  , hoping for the best and hoping that this, what I'm calling the AI wager, is going to work out to our advantage, but we'll see.”

As we move towards 2026, we are in a massive “upgrade moment” that most of us can feel. New pressures, new identities, new expectations on our work, our relationships, and our inner lives. Throughout the year, I've been speaking with professional creatives, climate and tech experts, teachers, neuroscientists, psychologists, and futureists about how AI can be used intelligently and ethically as a partnership to ensure we do not raise a generation that relies on machines to think for them. It’s not that we are being replaced by machines. It’s that we’re being invited to become a new kind of human. Where AI isn’t the headline; human transformation is. And that includes the arts, culture, and the whole of society. Generative AI – the technologies that write our emails, draft our reports, and even create art – have become a fixture of daily life, and the philosophical and moral questions they raise are no longer abstract. They are immediate, personal, and potentially disruptive to the core of what we consider human work.

Our guest today, Sven Nyholm, is one of the leading voices helping us navigate this new reality. As the Principal Investigator of AI Ethics at the Munich Center for Machine Learning, and co-editor of the journal Science and Engineering Ethics. He has spent his career dissecting the intimate relationship between humanity and the machine. His body of work systematically breaks down concepts that worry us all: the responsibility gap in autonomous systems, the ethical dimensions of human-robot interaction, and the question of whether ceding intellectual tasks to a machine fundamentally atrophies our own skills. His previous books, like Humans and Robots: Ethics, Agency, and Anthropomorphism, have laid the foundational groundwork for understanding these strange new companions in our lives.

His forthcoming book is The Ethics of Artificial Intelligence: A Philosophical Introduction. The book is a rigorous exploration of everything from algorithmic bias and opacity to the long-term existential risks of powerful AI. We’ll talk about what it means when an algorithm can produce perfect language without genuine meaning, why we feel entitled to take credit for an AI’s creation, and what this technological leap might be costing us, personally, as thinking, moral beings.

Episode Website

www.creativeprocess.info/pod

Instagram:@creativeprocesspodcast